 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: AUBAGIO (teriflunomide) |
|
***************************************************** |
|
#Post#: 3307-------------------------------------------------- |
|
Teriflunomide in relapsing MS: Outcomes by age, pre-treatment s |
|
tatus |
|
By: agate Date: June 2, 2021, 1:24 am |
|
--------------------------------------------------------- |
|
Several of the authors here are affiliated with Sanofi-Aventis. |
|
From Therapeutic Advances in Neurological Disorders (May 18, |
|
2021), "Teriflunnomide in relapsing multiple sclerosis: |
|
Outcomes by age and pre-treatment status": |
|
https://journals.sagepub.com/doi/full/10.1177/17562864211005588 |
|
***************************************************** |
